Prostate specific antigen density versus prostate specific antigen slope as predictors of prostate cancer in men with initially negative prostatic biopsies

Journal of Urology

Volumn 156, Issue 2, 1996, Pages 428-431

  Keetch, David W ^a,b   McMurtry, John M ^a   Smith, Deborah S ^a   Andriole, Gerald L ^a   Catalona, William J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Biopsy; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BIOPSY; BLOOD; CLINICAL TRIAL; CONFIDENCE INTERVAL; ECHOGRAPHY; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; PROSTATE; PROSTATE TUMOR; RISK; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; BIOPSY; CONFIDENCE INTERVALS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0030213867     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65868-3     Document Type: Article

References (17)

1. Keetch, D. W., Catalona, W. J. and Smith, D. S.: Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J. Urol., 151: 1571, 1994.
2. Ellis, W. J. and Brawer, M. K.: Repeat prostate needle biopsy: who needs it? J. Urol., 153: 1496, 1995.
3. Benson, M. C., Whang, I. S., Olsson, C. A., McMahon, D. J. and Cooner, W. H.: The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J. Urol., part 2, 147: 817, 1992.
4. Smith, D. S. and Catalona, W. J.: Rate of change in serum prostate specific antigen levels as a method for prostate cancer detection. J. Urol., 152: 1163, 1994.
5. Carter, H. B., Pearson, J. D., Metter, E. J., Brant, L. J., Chan, D. W., Andres, R., Fozard, J. L. and Walsh, P. C.: Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. J.A.M.A., 267: 2215, 1992.
6. Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D. E., Yuan, J. J. J., Petros, J. A. and Andriole, G. L.: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. New Engl. J. Med., 324: 1156, 1991.
7. Catalona, W. J., Smith, D. S., Ratliff, T. L. and Basler, J. W.: Detection of organ-confined prostate cancer is increased through prostate specific antigen-based screening. J.A.M.A., 270: 948, 1993.
8. Hosmer, D. W., Jr. and Lemeshow, S.: Applied Logistic Regression. New York: John Wiley and Sons, pp. 33-34, 1989.
9. Brawer, M. K., Beatie, J., Wener, M. H., Vessella, R. L., Preston, S. D. and Lange, P. H.: Screening for prostatic carcinoma with prostate specific antigen: results of the second year. J. Urol., 150: 106, 1993.
10. Catalona, W. J., Richie, J. P., Ahmann, F. R., Hudson, M. A., Scardino, P. T., Flanigan, R. C., deKernion, J. B., Ratliff, T. L., Kavoussi, L. R., Dalkin, B. L., Waters, W. B., MacFarlane, M. T. and Southwick, P. C.: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J. Urol., 151: 1283, 1994.
11. Partin, A. W., Carter, H. B., Chan, D. W., Epstein, J. I., Oesterling, J. E., Rock, R. C., Weber, J. P. and Walsh, P. C.: Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia. J. Urol., 143: 747, 1990.
12. Hasui, Y., Marutsuka, K., Asada, Y., Ide, H., Nishi, S. and Osada, Y.: Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia. Prostate, 25: 91, 1994.
13. Nadler, R. B., Humphrey, P. A., Smith, D. S., Catalona, W. J. and Ratliff, T. L.: Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J. Urol., 154: 407, 1995.
14. Lui, P. D., Terris, M. K., McNeal, J. E. and Stamey, T. A.: Indications for ultrasound guided transition zone biopsies in the detection of prostate cancer. J. Urol., part 2, 153: 1000, 1995.
15. Bazinet, M., Meshref, A. W., Trudel, C., Aronson, S., Péloquin, F., Nachabe, M., Bégin, L. R. and Elhilali, M. M.: Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma. Urology, 43: 44, 1994.
16. Brawer, M. K., Aramburu, E. A. G., Chen, G. L., Preston, S. D. and Ellis, W. J.: The inability of prostate specific antigen index to enhance the predictive value of prostate specific antigen in the diagnosis of prostatic carcinoma. J. Urol., 150: 369, 1993.
17. Catalona, W. J., Richie, J. P., deKernion, J. B., Ahmann, F. R., Ratliff, T. L., Dalkin, B. L., Kavoussi, L. R., MacFarlane, M. T. and Southwick, P. C.: Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves. J. Urol., 152: 2031, 1994.